KM	Staphylococcus simulans	-999	more	*kinetics and thermodynamics
KM	Staphylococcus simulans	-999	more	*kinetics of lysostaphin clearance of Staphylococcus aureus infection, overview
KM	Staphylococcus simulans	0.07	L-lysine(N-e-pentaglycine-N-(2-aminobenzoyl))-[N-(2,4-dinitrophenyl)ethylenediamine]	*value from Grafit and Hanes plot analyses
KM	Staphylococcus simulans	0.07	L-lysine(N-e-pentaglycyl-DABCYL)-EDANS	*value from Hanes plot analysis
KM	Staphylococcus simulans	0.08	L-lysine(N-e-pentaglycyl-DABCYL)-EDANS	*value from Grafit plot analysis
KM	Staphylococcus simulans	0.2	N-(2-Aminobenzoyl)pentaglycine-[N-(2,4-dinitrophenyl)ethylenediamine]	*value from Grafit plot analysis
KM	Staphylococcus simulans	0.3	N-(2-Aminobenzoyl)pentaglycine-[N-(2,4-dinitrophenyl)ethylenediamine]	*value from Hanes plot analysis
MW	Staphylococcus simulans	16260	*	*ESI-TOF MS, endopeptidase domain (residues 1-140)
MW	Bacillus virus phi29	18400	*	*N-terminal domain of gene product 13, 159 amino acids, calculated mass
MW	Bacillus virus phi29	22300	*	*C-terminal domain of gene product 13, 202 amino acids, calculated mass
MW	Staphylococcus simulans bv. staphylolyticus	24500	*	*sedimentation equilibrium, sedimentation and diffusion, gel filtration, polyacylamide electrophoresis
MW	Staphylococcus simulans	26800	*	*246 amino acids, mature peptide, recombinant enzyme
MW	Staphylococcus simulans	26900	*	*calculated from the plot of mobility versus log molecular weight of standards
MW	Staphylococcus simulans	26920	*	*mature lysostaphin, calculation from nucleotide sequence
MW	Staphylococcus simulans	27000	*	*mature enzyme
MW	Staphylococcus simulans	27000	*	*SDS-PAGE, mature enzyme
MW	Staphylococcus simulans	27000	*	*
MW	Staphylococcus simulans	27000	*	*1 * 27000, calculated from amino acid sequence
MW	Staphylococcus simulans	27000	*	*x * 27000, SDS-PAGE
MW	Staphylococcus simulans	27000	*	*x * 27000
MW	Staphylococcus simulans	27200	*	*theoretically estimated value
MW	Staphylococcus simulans	28010	*	*ESI-TOF MS, residues 247-493
MW	Staphylococcus simulans	29000	*	*Sephacryl S-200 gel filtration, His6-fused lysostaphin
MW	Staphylococcus capitis	35600	*	*mature enzyme, calculation from nucleotide sequence
MW	Staphylococcus capitis	39310	*	*proenzyme, calculation from nucleotide sequence
MW	Bacillus virus phi29	40900	*	*gp13 wild-type, 365 amino acids, calculated mass
MW	Staphylococcus simulans	42000	*	*preproenzyme
MW	Staphylococcus simulans	42210	*	*preprolysostaphin, calculation from nucleotide sequence
MW	Staphylococcus capitis	48000	*	*SDS-PAGE in presence and absence of reducing agents
MW	Staphylococcus simulans	49120	*	*prolysostaphin, calculation from nucleotide sequence. Prolysostaphin is processed to the mature enzyme by an extracellular cysteine protease
MW	Staphylococcus simulans	64000	*	*SDS-PAGE of prolysostaphin; the overestimated value is due to a high glutamate content. Prolysostaphin is processed to the mature enzyme by an extracellular cysteine protease
MW	Staphylococcus simulans	64000	*	*SDS-PAGE of prolysostaphin
SA	Staphylococcus simulans	-999	*	*169 U/mg (prolysostaphin), 760 U/mg (mature lysostaphin), 1 unit is defined as the amount of enzyme that causes 50% reduction of turbidity in 10 min at 37 C of an inactivated Staphylococcus carnosus TM300 cell suspension
SA	Staphylococcus simulans	-999	*	*assay method with N-acetylhexaglycine as substrate
SA	Staphylococcus simulans	-999	*	*
SA	Staphylococcus capitis	-999	*	*
SA	Staphylococcus simulans	-999	*	*
SA	Staphylococcus aureus	-999	*	*
SA	Staphylococcus simulans	-999	*	*
SA	Staphylococcus simulans	-999	*	*depending on the purification step the specific activity varied between 300 U/mg and 1500 U/mg
SA	Staphylococcus simulans	-999	*	*970 U/mg
SA	Staphylococcus simulans	-999	*	*11900 units per mg, after 12 fold purification, 1 unit is defined as the amount of enzyme required to decrease the OD(A600) of a suspension of Staphylococcus aureus 237 cells by 0.001 at 37&deg;C in 5 min in a 3 ml reaction volume
SA	Staphylococcus simulans	-999	*	*in vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from hospitals in Beijing, China, with MIC values of 30-2000 ng/ml, overview
SA	Staphylococcus simulans	-999	*	*activities of three enzymes namely, glycylglycine endopeptidase, endo-beta-N-acetyl glucosamidase and N-acteyl muramyl-L-alanine amidase. Lysostaphin rapidly lyses actively growing and non-dividing cells including staphylococci in biofilms. Glycylglycine endopeptidase lyses staphylococcal cells by hydrolyzing glycylglycine bonds in the polyglycine bridges which form cross links between glycopeptide chains in the cell wall peptidoglycan of Staphylococcus aureus cells. Lytic principle of lysostaphin is a peptidase which liberates N-terminal glycine and alanine from Staphylococcus aureus cell wall. Hexosaminidase is present in lysostaphin preparation is specific for the gluocainyl-muramic acid bond of the bacterial carbohydrate backbone
SA	Staphylococcus simulans	-999	*	*lysostaphin inhibits growth of methicillin-resistant Staphylococcus aureus USA300 at a concentration of 0.096 mg/ml. Growth inhibition of the two enzymes lysostaphin and LysK in combination is greater than either enzyme alone
SA	Staphylococcus simulans	-999	*	*treatment of methicillin-susceptible Staphylococcus aureus strain ATCC 25923 with lysostaphin results in major structural changes in the form of cell swelling, splitting of the septum, creation of nanoscale perforations, decrease of the bacterial spring constant and cell wall stiffness (atomic force microscopy)
SA	Bacillus virus phi29	-999	*	*gene product 13 is a protein at the tail tip of the Bacillus subtilis bacteriophage phi29 with D,D-endopeptidase functionality
SA	Staphylococcus simulans	-999	*	*FVB albino dams infected with methicillin-resistant Staphylococcus aureus for analysis of lysostaphin impact on pharmacokinetics, minimum inhibitory concentration(0.008 microg/ml) and minimum bactericidal concentration (0.015 microg/ml)
